Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Billy R Martin

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Pharmacology, Biochemistry, and Behavior|October 12, 2002
SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship studyCaroline E Bass, Graeme Griffin, Mark Grier, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2003
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsyMelisa J Wallace, Robert E Blair, Katherine W Falenski, et al.
Journal of the American Podiatric Medical Association|July 27, 2006
Verrucous hyperplasia: a common and problematic finding in the high-risk diabetic footMark Anthony Rosales, Billy R Martin, David G Armstrong, et al.
Bioorganic & Medicinal Chemistry|September 17, 2005
Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptorJohn W Huffman, Simon M Bushell, Sudhir N Joshi, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analoguesF Ivy Carroll, Lawrence E Brieaddy, Hernán A Navarro, et al.
European Journal of Pharmacology|January 16, 2007
Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptorsLaura E Wise, Christopher C Shelton, Benjamin F Cravatt, et al.
Journal of Natural Products|December 30, 2009
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonistsF Ivy Carroll, Wei Ma, Liu Deng, et al.
Experimental Neurology|February 10, 2007
Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticusLaxmikant S Deshpande, Robert E Blair, Nisha Nagarkatti, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptorJohn W Huffman, Simon M Bushell, John R A Miller, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 25, 2007
Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion modelMing Zhang, Billy R Martin, Martin W Adler, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Pharmacology, Biochemistry, and Behavior|October 12, 2002
SR-141716A-induced stimulation of locomotor activity. A structure-activity relationship studyCaroline E Bass, Graeme Griffin, Mark Grier, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 5, 2003
The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsyMelisa J Wallace, Robert E Blair, Katherine W Falenski, et al.
Journal of the American Podiatric Medical Association|July 27, 2006
Verrucous hyperplasia: a common and problematic finding in the high-risk diabetic footMark Anthony Rosales, Billy R Martin, David G Armstrong, et al.
Bioorganic & Medicinal Chemistry|September 17, 2005
Enantioselective synthesis of 1-methoxy- and 1-deoxy-2'-methyl-delta8-tetrahydrocannabinols: new selective ligands for the CB2 receptorJohn W Huffman, Simon M Bushell, Sudhir N Joshi, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analoguesF Ivy Carroll, Lawrence E Brieaddy, Hernán A Navarro, et al.
European Journal of Pharmacology|January 16, 2007
Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptorsLaura E Wise, Christopher C Shelton, Benjamin F Cravatt, et al.
Journal of Natural Products|December 30, 2009
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonistsF Ivy Carroll, Wei Ma, Liu Deng, et al.
Experimental Neurology|February 10, 2007
Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticusLaxmikant S Deshpande, Robert E Blair, Nisha Nagarkatti, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
1-Methoxy-, 1-deoxy-11-hydroxy- and 11-hydroxy-1-methoxy-Delta(8)-tetrahydrocannabinols: new selective ligands for the CB2 receptorJohn W Huffman, Simon M Bushell, John R A Miller, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|January 25, 2007
Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion modelMing Zhang, Billy R Martin, Martin W Adler, et al.
Pageof 11